Hayward, CA, United States of America

Mary Diane Feingersh

This inventor holds 6 USPTO granted patents and 1 published patent application. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mary Diane Feingersh. Retrieved from https://idiyas.com/inventor/mary-diane-feingersh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6 

% Patents Active = 83.3

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2019-2026

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations by Mary Diane Feingersh

Introduction

Mary Diane Feingersh is a prominent inventor based in Hayward, California. She has made significant contributions to the field of immunology, particularly through her work on monoclonal antibodies. With a total of five patents to her name, her innovations are paving the way for advancements in cancer treatment and immune response enhancement.

Latest Patents

One of her latest patents is titled "Anti-ICOS agonist antibodies and uses thereof." This invention provides isolated monoclonal antibodies that bind to human Inducible T Cell COStimulator (ICOS) and exhibit therapeutically desirable functional properties. These antibodies can stimulate human ICOS activity, which is crucial for enhancing immune responses. The patent also includes nucleic acid molecules encoding the antibodies, expression vectors, and methods for expressing these antibodies. Additionally, it covers immunoconjugates, bispecific molecules, and pharmaceutical compositions that incorporate these antibodies. The applications of her invention are significant, as they can be used to stimulate antigen-specific T cell responses against tumors or viral antigens. Furthermore, these antibodies can be combined with other therapeutic antibodies to treat cancer effectively.

Career Highlights

Mary Diane Feingersh is currently associated with Bristol-Myers Squibb Company, where she continues to innovate in the field of immunotherapy. Her work has been instrumental in developing new therapeutic strategies that leverage the immune system to combat diseases.

Collaborations

She has collaborated with notable colleagues such as John J Engelhardt and Mark J Selby, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Mary Diane Feingersh's contributions to the field of immunology through her patents and collaborations highlight her role as a leading inventor. Her work not only advances scientific knowledge but also has the potential to improve therapeutic outcomes for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…